Lymphatics in bone arise from pre-existing lymphatics

被引:22
作者
Monroy, Marco [1 ,2 ]
McCarter, Anna L. [1 ,2 ]
Hominick, Devon [1 ,2 ]
Cassidy, Nina [1 ,2 ]
Dellinger, Michael T. [1 ,2 ,3 ,4 ]
机构
[1] UT Southwestern Med Ctr, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
[3] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA
[4] UT Southwestern Med Ctr, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA
来源
DEVELOPMENT | 2020年 / 147卷 / 21期
基金
美国国家卫生研究院;
关键词
Gorham-Stout disease; Generalized lymphatic anomaly; VEGF-C; PIK3CA; Rapamycin; ENDOTHELIAL-CELLS; HEMOGENIC ENDOTHELIUM; GROWTH-FACTOR; SIROLIMUS; OSTEOPETROSIS; CONTRIBUTE; MUTATIONS; PHENOTYPE; ORIGIN; GENE;
D O I
10.1242/dev.184291
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bones do not normally have lymphatics. However, individuals with generalized lymphatic anomaly (GLA) or Gorham-Stout disease (GSD) develop ectopic lymphatics in bone. Despite growing interest in the development of tissue-specific lymphatics, the cellular origin of bone lymphatic endothelial cells (bLECs) is not known and the development of bone lymphatics has not been fully characterized. Here, we describe the development of bone lymphatics in mouse models of GLA and GSD. Through lineage-tracing experiments, we show that bLECs arise from pre-existing Proxl -positive LECs. We show that bone lymphatics develop in a stepwise manner where regional lymphatics grow, breach the periosteum and then invade bone. We also show that the development of bone lymphatics is impaired in mice that lack osteoclasts. Last, we show that rapamycin can suppress the growth of bone lymphatics in our models of GLA and GSD. In summary, we show that bLECs can arise from pre-existing LECs and that rapamycin can prevent the growth of bone lymphatics.
引用
收藏
页数:14
相关论文
共 36 条
[1]   Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies [J].
Adams, Denise M. ;
Trenor, Cameron C., III ;
Hammill, Adrienne M. ;
Vinks, Alexander A. ;
Patel, Manish N. ;
Chaudry, Gulraiz ;
Wentzel, Mary Sue ;
Mobberley-Schuman, Paula S. ;
Campbell, Lisa M. ;
Brookbank, Christine ;
Gupta, Anita ;
Chute, Carol ;
Eile, Jennifer ;
McKenna, Jesse ;
Merrow, Arnold C. ;
Fei, Lin ;
Hornung, Lindsey ;
Seid, Michael ;
Dasgupta, A. Roshni ;
Dickie, Belinda H. ;
Elluru, Ravindhra G. ;
Lucky, Anne W. ;
Weiss, Brian ;
Azizkhan, Richard G. .
PEDIATRICS, 2016, 137 (02)
[2]   Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation [J].
Adams, Jessica R. ;
Xu, Keli ;
Liu, Jeff C. ;
Agamez, Natalia M. Ruiz ;
Loch, Amanda J. ;
Wong, Ruth G. ;
Wang, Wei ;
Wright, Katherine L. ;
Lane, Timothy F. ;
Zacksenhaus, Eldad ;
Egan, Sean E. .
CANCER RESEARCH, 2011, 71 (07) :2706-2717
[3]   Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract [J].
Baluk, Peter ;
Yao, Li-Chin ;
Flores, Julio C. ;
Choi, Dongwon ;
Hong, Young-Kwon ;
McDonald, Donald M. .
JCI INSIGHT, 2017, 2 (16)
[4]   PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations [J].
Blesinger, Hannah ;
Kaulfuss, Silke ;
Aung, Thiha ;
Schwoch, Sonja ;
Prantl, Lukas ;
Roessler, Jochen ;
Wilting, Joerg ;
Becker, Juergen .
PLOS ONE, 2018, 13 (07)
[5]   AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation [J].
Boscolo, Elisa ;
Coma, Silvia ;
Luks, Valerie L. ;
Greene, Arin K. ;
Klagsbrun, Michael ;
Warman, Matthew L. ;
Bischoff, Joyce .
ANGIOGENESIS, 2015, 18 (02) :151-162
[6]  
Chen W, 2014, PLOS ONE, V9
[7]   Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo [J].
Conrad, Claudius ;
Niess, Hanno ;
Huss, Ralf ;
Huber, Stephan ;
von Luettichau, Irene ;
Nelson, Peter J. ;
Ott, Harald C. ;
Jauch, Karl-Walter ;
Bruns, Christiane J. .
CIRCULATION, 2009, 119 (02) :281-289
[8]   Gorham-Stout Disease Successfully Treated With Sirolimus and Zoledronic Acid Therapy [J].
Cramer, Stuart L. ;
Wei, Shi ;
Merrow, Arnold C. ;
Pressey, Joseph G. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (03) :E129-E132
[9]   Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects [J].
Dai, XM ;
Ryan, GR ;
Hapel, AJ ;
Dominguez, MG ;
Russell, RG ;
Kapp, S ;
Sylvestre, V ;
Stanley, ER .
BLOOD, 2002, 99 (01) :111-120
[10]   Viewpoints on vessels and vanishing bones in Gorham-Stout disease [J].
Dellinger, Michael T. ;
Garg, Nupur ;
Olsen, Bjorn R. .
BONE, 2014, 63 :47-52